PLRZ
Polyrizon Ltd. Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$31.13M
P/E Ratio
—
EPS
$-4.90
Beta
—
52W High
$2235.00
52W Low
$2.88
50-Day MA
$13.09
200-Day MA
$9.45
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Polyrizon Ltd. Ordinary Shares
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company is headquartered in Ra'anana, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-5.91M |
| Operating Margin | 0.00% |
| Return on Equity | -25.40% |
| Return on Assets | -28.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $13.05 |
| Price-to-Book | 1.48 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.87M |
| Float | $1.54M |
| % Insiders | 0.96% |
| % Institutions | 2.22% |
Historical Volatility
HV 10-Day
85.50%
HV 20-Day
95.22%
HV 30-Day
97.41%
HV 60-Day
111.12%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/28/2026